Terms: = Leukemia AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254 AND Diagnosis
316 results:
1. Genetic mutations and immune microenvironment: unveiling the connection to AML prognosis.
Hu Z; Yang Y; Li J; Hu Z
Hematology; 2024 Dec; 29(1):2346965. PubMed ID: 38687637
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era.
Iat A; Loschi M; Benachour S; Calleja A; Chiche E; Sudaka I; Aquaronne D; Ferrero C; Fenwarth L; Marceau A; Fournier E; Dadone-Montaudie B; Cluzeau T
Cancer Med; 2024 Mar; 13(6):e7103. PubMed ID: 38506267
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical analysis of allogeneic hematopoietic stem cell transplantation for seven cases of acute myeloid leukemia with BCR::ABL1 fusion].
Hao MZ; Zhao XL; Zhang XY; Shi YY; Gong M; Zhang LN; Chen SL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):995-1000. PubMed ID: 38503522
[No Abstract] [Full Text] [Related]
4. The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia.
Paterno G; Palmieri R; Tesei C; Nunzi A; Ranucci G; Mallegni F; Moretti F; Meddi E; Tiravanti I; Marinoni M; Page C; Fagiolo S; Buzzatti E; Secchi R; Gurnari C; Maurillo L; Buccisano F; Venditti A; Del Principe MI
Thromb Res; 2024 Apr; 236():30-36. PubMed ID: 38387301
[TBL] [Abstract] [Full Text] [Related]
5. Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study.
Didi I; Alliot JM; Dumas PY; Vergez F; Tavitian S; Largeaud L; Bidet A; Rieu JB; Luquet I; Lechevalier N; Delabesse E; Sarry A; De Grande AC; Bérard E; Pigneux A; Récher C; Simoncini D; Bertoli S
Leuk Res; 2024 Jan; 136():107437. PubMed ID: 38215555
[TBL] [Abstract] [Full Text] [Related]
6. Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk npm1-mutated AML.
Chan O; Al Ali N; Tashkandi H; Ellis A; Ball S; Grenet J; Hana C; Deutsch Y; Zhang L; Hussaini M; Song J; Yun S; Talati C; Kuykendall A; Padron E; Walker A; Roboz G; Desai P; Sallman D; Sweet K; Komrokji R; Lancet J
Blood Adv; 2024 Mar; 8(5):1075-1083. PubMed ID: 38170740
[TBL] [Abstract] [Full Text] [Related]
7. Reduced duration and dosage of venetoclax is efficient in newly diagnosed patients with acute myeloid leukemia.
Cui J; Chen X; Li C; Yan Q; Yuan G
Hematology; 2024 Dec; 29(1):2293512. PubMed ID: 38095287
[TBL] [Abstract] [Full Text] [Related]
8. Understanding differential technologies for detection of MRD and how to incorporate into clinical practice.
Cloos J; Ngai LL; Heuser M
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):682-690. PubMed ID: 38066915
[TBL] [Abstract] [Full Text] [Related]
9. [Effect of clonal hematopoiesis in remission on hematopoiesis recovery in patients with npm1 mutated acute myeloid leukemia after chemotherapy].
Wang LL; Chen SN
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):845-850. PubMed ID: 38049337
[No Abstract] [Full Text] [Related]
10. Test Then Erase? Current Status and Future Opportunities for Measurable Residual Disease Testing in Acute Myeloid leukemia.
Blackmon AL; Hourigan CS
Acta Haematol; 2024; 147(2):133-146. PubMed ID: 38035547
[TBL] [Abstract] [Full Text] [Related]
11. Clinical significance of WT1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia.
Yu T; Zhan Q; Yan X; Luo X; Wang X; Tang X; Zhang H; Yang Z; Chen J; Liu L; Wang L
Cancer Biol Ther; 2023 Dec; 24(1):2285801. PubMed ID: 38031921
[TBL] [Abstract] [Full Text] [Related]
12. Genomic Mutation Profiles of Patients with Acute Myeloid leukemia in Korea: a Single-Center Experience.
Han E; Ryu S; Kim D; Koh EH; Byun JH; Lee DH
Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948498
[TBL] [Abstract] [Full Text] [Related]
13. MLPA in the initial genetic screening of patients with acute myeloid leukemia.
Yahya D; Hachmeriyan M; Ruseva T; Chervenkov T; Micheva I
Rom J Intern Med; 2024 Mar; 62(1):44-51. PubMed ID: 37948316
[TBL] [Abstract] [Full Text] [Related]
14. Automated Deep Learning-Based diagnosis and Molecular Characterization of Acute Myeloid leukemia Using Flow Cytometry.
Lewis JE; Cooper LAD; Jaye DL; Pozdnyakova O
Mod Pathol; 2024 Jan; 37(1):100373. PubMed ID: 37925056
[TBL] [Abstract] [Full Text] [Related]
15. Criteria for diagnosis and Molecular Monitoring of npm1-Mutated AML.
Falini B; Dillon R
Blood Cancer Discov; 2024 Jan; 5(1):8-20. PubMed ID: 37917833
[TBL] [Abstract] [Full Text] [Related]
16. Blasts with folded nuclei: A histopathologic finding in myeloid leukemia cutis with npm1 and FLT3 mutations.
Han S; Patel T; Garcia ML; Tirado M
J Cutan Pathol; 2024 Feb; 51(2):130-134. PubMed ID: 37866827
[TBL] [Abstract] [Full Text] [Related]
17. Vitamin C and D supplementation in acute myeloid leukemia.
Mouchel PL; Bérard E; Tavitian S; Gadaud N; Vergez F; Rieu JB; Luquet I; Sarry A; Huguet F; Largeaud L; Delabesse E; Huynh A; Bertoli S; Récher C
Blood Adv; 2023 Nov; 7(22):6886-6897. PubMed ID: 37671973
[TBL] [Abstract] [Full Text] [Related]
18. Application of the International Consensus Classification and World Health Organization 5th edition classification to a series of myeloid neoplasms.
Chopra S; Bailey NG
Am J Clin Pathol; 2023 Dec; 160(6):566-570. PubMed ID: 37587830
[TBL] [Abstract] [Full Text] [Related]
19. [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].
Qu SQ; Pan LJ; Qin TJ; Xu ZF; Li B; Wang HJ; Sun Q; Jia YJ; Li CW; Cai WY; Gao QY; Jiao M; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):373-379. PubMed ID: 37550186
[No Abstract] [Full Text] [Related]
20. Phenotypic clues that predict underlying cytogenetic/genetic abnormalities in myeloid malignancies: A contemporary review.
Stone M; Lilley CM; Tang G; Loghavi S; Mirza KM
Cytopathology; 2023 Nov; 34(6):530-541. PubMed ID: 37522274
[TBL] [Abstract] [Full Text] [Related]
[Next]